| Use of erythropoietin in heart failure management. | |
| | |
MedLine Citation:
|
PMID: 15494385 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To review the use of erythropoietin for anemia in heart failure (HF). DATA SOURCES: Peer-reviewed articles in MEDLINE (1966-June 2004) were identified and citations from available articles were reviewed using the search terms anemia, erythropoietin, and heart failure. DATA SYNTHESIS: Anemia worsens HF prognosis. Clinical studies in patients with New York Heart Association Class III/IV HF who had hemoglobin <12 mg/dL and were refractory to maximal medical management showed that erythropoietin improves symptoms. Larger scale studies with mortality endpoints are required to confirm the benefits. CONCLUSIONS: In selected patients with severe, chronic HF, erythropoietin may be considered for functional improvement. However, routine use of this treatment strategy is not recommended until more data are available. |
| | |
Authors:
|
Krista Caiola; Judy W M Cheng |
Related Documents
:
|
7352125 - Perioperative care of patients with cardiac disease. 16936475 - Heart rate slowing for myocardial dysfunction/heart failure. 14583355 - Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in p... 3291595 - Arrhythmias, catecholamines and electrolytes. 11758065 - Focal angiogenic therapy for myocardial ischemia. 20153355 - Multistability property in cardiac ionic models of mammalian and human ventricular cells. |
Publication Detail:
|
Type: Journal Article; Review Date: 2004-10-19 |
Journal Detail:
|
Title: The Annals of pharmacotherapy Volume: 38 ISSN: 1060-0280 ISO Abbreviation: Ann Pharmacother Publication Date: 2004 Dec |
Date Detail:
|
Created Date: 2004-11-16 Completed Date: 2005-01-31 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9203131 Medline TA: Ann Pharmacother Country: United States |
Other Details:
|
Languages: eng Pagination: 2145-9 Citation Subset: IM |
Affiliation:
|
Mount Sinai Hospital, New York, NY 10029, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anemia
/
complications,
drug therapy* Erythropoietin / therapeutic use* Heart Failure / complications, drug therapy* Hematinics / therapeutic use* Humans Randomized Controlled Trials as Topic Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Hematinics; 11096-26-7/Erythropoietin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adjunctive granulocyte colony-stimulating factor therapy for diabetic foot infections.
Next Document: Probable sulbactam/ampicillin-associated prolonged cholestasis.